Literature DB >> 17267762

Artificially generated dendritic cells misdirect antiviral immune responses.

Cariosa Noone1, Ellen Manahan, Robert Newman, Patricia Johnson.   

Abstract

Dendritic cells (DCs) are critical to the outcome of many viral infections. Questions still remain as to the relevance of artificially generated DCs in models of in vivo immune responses. We compared different DC generation pathways, in terms of phenotypic expression, cytokine production, apoptosis, and T cell proliferation, following viral infection. Direct viral infection of monocytes or monocytes cultured with supernatants from virally infected lung epithelial cells (A549 DCs) induce distinct DC subsets compared with viral infection of artificially generated IL-4 DCs and IFN-DCs. These virally infected DC subsets stimulated different cytokine secretion profiles and displayed contrasting sensitivities to viral-induced apoptosis. It is most interesting that we observed marked differences in the proliferation of purified CD3+ T cells from the virally infected DC subsets. In conclusion, artificially generated DCs skew immune responses to viral infections, and direct viral infection of monocytes and DCs, generated from monocytes cultured with supernatants from infected epithelial cells, appears to be a more relevant pathway of producing DCs, which mimic those generated in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267762     DOI: 10.1189/jlb.1006615

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  2 in total

1.  Natural killer cells regulate T-cell proliferation during human parainfluenza virus type 3 infection.

Authors:  Cariosa M Noone; Elaine Paget; Ellen A Lewis; Marius R Loetscher; Robert W Newman; Patricia A Johnson
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

2.  Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-γ responses to pneumococcus in vitro in human monocytes.

Authors:  Sinead T Loughran; Patrick A Power; Paula T Maguire; Samantha L McQuaid; Paul J Buchanan; Ingileif Jonsdottir; Robert W Newman; Ruth Harvey; Patricia A Johnson
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.